<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study of 49 patients with spontaneous venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> identified 27 with <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e>: 13 had only <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (VT), six had episodes of VT followed by <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (AT) and eight had AT only </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 27 patients were less than 42 years of age; 22 had specific natural <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> or fibrinolytic deficiencies: antithrombin III (nine patients), protein C (eight patients), protein S (three patients), <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor II (two patients), tissue plasminogen activator release (one patient) and mixed antithrombin III and protein S (one patient) </plain></SENT>
<SENT sid="2" pm="."><plain>The remaining five patients had recurrent thrombotic events associated with resistance to <z:chebi fb="5" ids="28304">heparin</z:chebi> anticoagulation, but no established laboratory diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>Clotting complications included recurrent VT, <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, multiple failed arterial procedures and lower extremity <z:mpath ids='MPATH_686'>amputation</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>The remaining 22 patients (mean age of 53 years, range of 46 to 63 years), 12 with VT and ten with AT, did not have laboratory evidence of <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> and none had recurrent <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these patients were successfully treated by conventional therapy without any additional thrombotic events during the follow-up period </plain></SENT>
<SENT sid="6" pm="."><plain>Young adults with spontaneous thrombotic events should be screened for possible <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, these young patients need further evaluation and treatment of <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Those with <z:hpo ids='HP_0004416'>premature atherosclerosis</z:hpo> have an especially poor prognosis despite surgical intervention and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
</text></document>